Immunotherapy for Prostate Cancer: Where We Are Headed

Prostate cancer is one of the most common malignant neoplasms in men worldwide, and is the fifth cause of cancer-related death. In recent years, a new generation of therapies have been approved for the management of metastatic disease. Moreover, the development of new immunotherapeutic drugs has bec...

Descripción completa

Detalles Bibliográficos
Autores principales: Schepisi, Giuseppe, Farolfi, Alberto, Conteduca, Vincenza, Martignano, Filippo, De Lisi, Delia, Ravaglia, Giorgia, Rossi, Lorena, Menna, Cecilia, Bellia, Salvatore Roberto, Barone, Domenico, Gunelli, Roberta, De Giorgi, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751230/
https://www.ncbi.nlm.nih.gov/pubmed/29206214
http://dx.doi.org/10.3390/ijms18122627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751230/
https://www.ncbi.nlm.nih.gov/pubmed/29206214
http://dx.doi.org/10.3390/ijms18122627

Ejemplares similares